Extension of the approval periods of the active substances 2-phenylphenol, 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron

(1)

in the sixth column, expiration of approval, of row 18, 8-hydroxyquinoline, the date is replaced by ‘31 December 2022’;

(2)

in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2022’;

(3)

in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2022’;

(4)

in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2022’;

(5)

in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2022’;

(6)

in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2022’;

(7)

in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2022’;

(8)

in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2022’;

(9)

in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2022’;

(10)

in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2022’;

(11)

in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2022’;

(12)

in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2022’;

(13)

in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2022’;

(14)

in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2022’;

(15)

in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2022’;

(16)

in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2022’;

(17)

in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2022’;

(18)

in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2022’;

(19)

in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2022’;

(20)

in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2022’;

(21)

in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2022’;

(22)

in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2022’;

(23)

in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2022’;

(24)

in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2022’;

(25)

in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2022’;

(26)

in the sixth column, expiration of approval, of row 276, Chlormequat, the date is replaced by ‘30 November 2022’;

(27)

in the sixth column, expiration of approval, of row 278, Propaquizafop, the date is replaced by ‘30 November 2022’;

(28)

in the sixth column, expiration of approval, of row 279, Quizalofop-P-ethyl and Quizalofop-P-tefuryl, the date is replaced by ‘30 November 2022’;

(29)

in the sixth column, expiration of approval, of row 284, Dimethachlor, the date is replaced by ‘31 December 2022’;

(30)

in the sixth column, expiration of approval, of row 285, Etofenprox, the date is replaced by ‘31 December 2022’;

(31)

in the sixth column, expiration of approval, of row 287, Penconazole, the date is replaced by ‘31 December 2022’;

(32)

in the sixth column, expiration of approval, of row 288, Tri-allate, the date is replaced by ‘31 December 2022’;

(33)

in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2022’;

(34)

in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2022’;

(35)

in the sixth column, expiration of approval, of row 293, Tetraconazole, the date is replaced by ‘31 December 2022’;

(36)

in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2022’;

(37)

in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘31 December 2022’;

(38)

in the sixth column, expiration of approval, of row 299, 2-phenylphenol (including its salts such as the sodium salt), the date is replaced by ‘31 December 2022’.